Biotech2 hours ago
Spain Prioritizes Clinical Benefit Over Efficiency in Funding New Cancer Drugs
Spain’s funding of new cancer drugs hinges mainly on substantial clinical benefit and quality-of-life data, while efficiency and innovation have little influence. Evidence quality speeds decisions,...